EP2451517B1 - System und verfahren zur erfassung der atmung einer person - Google Patents

System und verfahren zur erfassung der atmung einer person Download PDF

Info

Publication number
EP2451517B1
EP2451517B1 EP10740730.6A EP10740730A EP2451517B1 EP 2451517 B1 EP2451517 B1 EP 2451517B1 EP 10740730 A EP10740730 A EP 10740730A EP 2451517 B1 EP2451517 B1 EP 2451517B1
Authority
EP
European Patent Office
Prior art keywords
subject
exhalation
resistance
valves
bodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP10740730.6A
Other languages
English (en)
French (fr)
Other versions
EP2451517A1 (de
Inventor
Vijay Kumar Iyer
Michael Edward Colbaugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips NV filed Critical Koninklijke Philips NV
Publication of EP2451517A1 publication Critical patent/EP2451517A1/de
Application granted granted Critical
Publication of EP2451517B1 publication Critical patent/EP2451517B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/08—Bellows; Connecting tubes ; Water traps; Patient circuits
    • A61M16/0866—Passive resistors therefor
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63B—APPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
    • A63B23/00—Exercising apparatus specially adapted for particular parts of the body
    • A63B23/18—Exercising apparatus specially adapted for particular parts of the body for improving respiratory function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0683—Holding devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0088—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus modulated by a simulated respiratory frequency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • A61M2230/06—Heartbeat rate only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/30—Blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics
    • A61M2230/42—Rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/60—Muscle strain, i.e. measured on the user
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63B—APPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
    • A63B24/00—Electric or electronic controls for exercising apparatus of preceding groups; Controlling or monitoring of exercises, sportive games, training or athletic performances
    • A63B24/0087—Electric or electronic controls for exercising apparatus of groups A63B21/00 - A63B23/00, e.g. controlling load
    • A63B2024/0093—Electric or electronic controls for exercising apparatus of groups A63B21/00 - A63B23/00, e.g. controlling load the load of the exercise apparatus being controlled by performance parameters, e.g. distance or speed
    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63B—APPARATUS FOR PHYSICAL TRAINING, GYMNASTICS, SWIMMING, CLIMBING, OR FENCING; BALL GAMES; TRAINING EQUIPMENT
    • A63B21/00—Exercising apparatus for developing or strengthening the muscles or joints of the body by working against a counterforce, with or without measuring devices
    • A63B21/008—Exercising apparatus for developing or strengthening the muscles or joints of the body by working against a counterforce, with or without measuring devices using hydraulic or pneumatic force-resisters
    • A63B21/0085—Exercising apparatus for developing or strengthening the muscles or joints of the body by working against a counterforce, with or without measuring devices using hydraulic or pneumatic force-resisters using pneumatic force-resisters

Definitions

  • the invention relates to the entrainment of breathing of a subject using a respiration appliance that restricts exhalation while permitting substantially unencumbered inhalation.
  • Hypertension is a significant problem in nearly all western cultures and is an underlying cause for stroke and heart attack. Termed the "Silent Killer,” hypertension affects approximately 1 in 4 Americans, and occurs with even higher prevalence in some European communities. Hypertension is also gaining recognition as a co-morbid factor in obstructed sleep apnea (OSA) patient populations, with recent studies indicating that as many as 80% of patients seeking treatment for OSA may unknowingly suffer from this disease.
  • OSA sleep apnea
  • US 3,710,780 A discloses a device to permit more efficient breathing by medical patients comprising a mouthpiece having a passage portion for communication with the patient's mouth and inlet and outlet passages communicating with the first passage portion.
  • the inlet and outlet passages are provided, respectively, with inlet and outlet check valves.
  • a flexible conduit extends from the outlet check valve portion of the mouthpiece to a receptacle containing a liquid and the outlet end of the flexible conduit is immersed in the liquid to an adjusted depth to interpose a predetermined variable fluid resistance to airflow from said mouthpiece outlet passage by way of said conduit.
  • the respiration appliance configured to entrain the breathing of a subject.
  • the respiration appliance comprises one or more bodies, and one or more valves.
  • the one or more bodies are configured to enclose one or more external orifices of the airway of a subject, wherein the one or more bodies form one ormore flow paths between the enclosed one or more external orifices of the airway of the subject and ambient atmosphere.
  • the one or more valves are disposed in the one or more bodies, the one or more valves being configured to provide ( i ) a cumulative inhalation resistance to gas flow within the one or more flow paths formed by the one or more bodies to gas flowing from ambient atmosphere to the one or more external orifices of the airway of the subject enclosed by the one or more bodies, and (ii) a cumulative exhalation resistance to gas flow within the one or more flow paths formed by the one or more bodies to gas flowing from the one or more external orifices of the airway of the subject enclosed by the one or more bodies to ambient atmosphere.
  • the cumulative inhalation resistance is low enough that the subject can inhale freely ambient atmosphere through the one or more bodies.
  • the cumulative exhalation resistance is higher than the cumulative inhalation resistance, and is selected to restrict the exhalation of the subject to extend the exhalation time of the subject, thereby entraining the breathing of the subject while the subject is conscious to modulate the autonomic nervous system of the subject to decrease sympathetic nerve activity and/or to reduce sympathetic/parasympathetic balance in order to provide relaxation to the subject.
  • the respiration appliance further comprises a training cue generator configured to generate breathing cues to the subject that prompt the subject to reduce a pressure differential between the one or more flow paths formed by the one or more bodies and ambient atmosphere only if the pressure differential breaches a threshold pressure differential.
  • FIG. 1 illustrates a respiration appliance 10 configured to entrain the breathing of a subject 12, in accordance with one or more embodiments of this disclosure.
  • the entrainment of the breathing of subject 12 is designed to modulate the autonomic nervous system of subject 12 to decrease sympathetic nerve activity and/or to reduce sympathetic/parasympathetic balance in order to provide relaxation to subject 12.
  • the respiration appliance 10 restricts the exhalation of subject 12 to extend the exhalation time of subject 12, which then impacts autonomic nervous system of subject 12 in the intended manner.
  • the entrainment of the breathing of subject 12 may include impacting in a predetermined manner one or more physiological parameters of subject 12 related to respiratory rate and/or tidal volume.
  • respiration appliance 10 includes one or more bodies 14 that enclose one or more external orifices (e.g., nostrils) of the airway of subject 12, and a fastener 16.
  • Fastener 16 holds body 14 in place over the one or more external orifices of the airway of subject 12.
  • fastener 16 is a single strap that loops around the head of subject 12.
  • fastener 16 includes a headgear having a different configuration for engaging the head of fastener 16 to hold body 14 in place.
  • fastener 16 includes a structure that engages the interior of the one or more openings of the airway of subject 12, and/or an adhesive that attaches to the skin of subject 12 to hold body 14 in place.
  • respiration appliance 10 may be implemented and/or formed integrally with an oral appliance and/or headgear that holds the lower jaw of subject 12 in a position that opens the airway of subject 12 (e.g., with the lower jaw extended forward), and/or holds the mouth of subject 12 closed to encourage breathing through the nostrils.
  • FIG. 2 shows an enlarged view of body 14, according to one or more embodiments of this disclosure.
  • body 14 forms a plurality of openings with flow paths therebetween.
  • the interior of body 14 is hollow, and without substantial impediment to the flow of gas from any of the various openings to any of the other various openings.
  • the plurality of openings include one or more subject interface openings 18, a set of inhalation ports 20 and a set of exhalation ports 22.
  • the subject interface openings 18 communicate gas within the flow paths formed inside of body 14 with the airway of subject 12.
  • body 14 forms a first subset of flow paths between inhalation ports 20 and subject interface openings 18 that deliver gas from ambient atmosphere to the one or more external orifices of the airway of subject 12 during inhalation.
  • Body 14 forms a second subset of flow paths between exhalation ports 22 and subject interface openings 18 that deliver gas from the one or more external orifices of subject 12 to ambient atmosphere during exhalation.
  • subject interface openings 18 are formed by airway enclosing members 24.
  • FIG. 2 depicts airway enclosing members 24 as nasal pillows that enclose the nostrils of subject 12.
  • Airway enclosing members 24 may be selectably detachable from the rest of body 14. This will facilitate cleaning and/or replacement of airway enclosing members 24 for hygienic purposes, and/or selection of airway enclosing members 24 by subject 12 based on personal preference ( e.g ., from members having different sizes, different sized openings, etc. ) .
  • respiration appliance 10 includes a set of inhalation valves 26.
  • Inhalation valves 26 permit gas to flow relatively freely from ambient atmosphere into the flow paths formed within body 14 through inhalation ports 20, but significantly resist or seal the flow of gas from within body 14 to ambient atmosphere through inhalation ports 20.
  • inhalation valves 26 may be "one way" valves that permit gas to flow freely into body 14 from atmosphere, but block gas within body 14 from flowing to atmosphere.
  • the flow paths formed within body between inhalation ports 20 and subject interface openings 18 allow gas to be drawn freely from inhalation ports 20 tao subject interface openings 18 and into the nostrils of subject 12.
  • inhalation valves 26 significantly resist or seal the flow of exhaled gas from the nostrils of subject 12 to ambient atmosphere through the first subset of flow paths formed within body 14 from subject interface openings 18 to inhalation ports 20.
  • inhalation valves 26 are selectably detachable from the rest of body 14. This facilitates cleaning of valves 26 and/or body 14, and may enable valves 26 to be replaced for hygienic purposes, or if one of inhalation valves 26 stops functioning correctly.
  • gas flowing "freely" from ambient atmosphere through inhalation ports 20 refers to gas flows that experience a relatively small amount of resistance such that the inhalation of this gas requires approximately the same amount of.effort on the part of subject as inhalation without the respiration appliance 10.
  • the resistance of inhalation valves 26 to gas flowing from ambient atmosphere into body 14 is small enough that the cumulative resistance of respiration appliance 10 to gas inhaled by subject 12 through body 14 is less than or equal to about 0.025 cm H 2 O/LPM (at 30 LPM flow).
  • the resistance of inhalation valves 26 to gas flowing from ambient atmosphere into body 14 is small enough that the cumulative resistance of respiration appliance 10 to gas inhaled by subject 12 through body 14 is less than or equal to about 0.017 cm H 2 O/LPM (at 30 LPM flow). Cumulative resistance is the overall resistance of respiration appliance 10 for a volume of gas flowing into a first set of openings in respiration appliance 10, through respiration appliance 10, and out of respiration appliance via a second set of openings in respiration appliance 10.
  • respiration appliance 10 includes a set of exhalation valves 28.
  • Exhalation valves 28 regulate the flow of gas between the nostrils of subject 12 and ambient atmosphere within the second subset of flow paths formed inside body 14 between subject interface openings 18 and exhalation ports 22.
  • exhalation valves 28 provide a resistance to the flow of gas from the nostrils of subject 12 to ambient atmosphere in the second subset of flow paths during exhalation.
  • the resistance provided by exhalation valves 28 to these flows of exhaled gas primarily characterize a cumulative resistance of respiration appliance 10 to gas being exhaled from the nostrils of subject 12.
  • the tidal volume of respiration will tend to increase to an inflated level to compensate for the lower breath rate. Over time, as subject 12 relaxes and ventilatory demand is reduced, the tidal volume will decrease from this inflated level as autonomic nervous system arousal abates and the respiratory rate and tidal volume settle at equilibrium values. However, these equilibrium values will still be different from the unencumbered breathing of subject 12. In particular, the tidal volume will be increased with respect to unencumbered breathing, and the respiratory rate will be decreased with respect to unencumbered breathing.
  • FIG. 4 is a plot illustrating the impact that different cumulative resistances to exhalation will have on respiratory rate. In particular, FIG. 4 is a plot illustrating the impact that cumulative resistance will have on entraining the respiration of the subject while the subject is conscious. The restriction of exhalation flow by respiration appliance 10 will also tend to entrain the respiration of the subject while the subject is asleep.
  • the user of the appliance 10 may be instructed not strain against the restricted flow during expiration. Excessive straining by the subject during exhalation may increase the pressure within respiration appliance 10 to levels that reduce the therapeutic value of respiration appliance 10, and may not enable the autonomic nervous system to be impacted in the desired manner.
  • the instruction may be provided in the form of text provide on respiration appliance 10, one or more pictures, audible instructions, and/or other instructions.
  • the exhalation valves 28 and/or inhalation valves 26 of respiration appliance 10 may be configured to provide a cumulative resistance to exhalation of between about .025 and about 2.0 cm-H 2 O/LPM (at 10 LPM flow). In one embodiment, the cumulative resistance to exhalation may be between about .025 and about 1.0 cm-H 2 O/LPM (at 10 LPM flow). In one embodiment, the cumulative resistance to exhalation may be between about .025 and about .45 cm-H 2 O/LPM (at 10 LPM flow). In one embodiment, the cumulative resistance to exhalation may be between about 15 and about 45 cm-H 2 O/LPM (at 10 LPM flow).
  • exhalation valves 28 have a different resistance to gas flowing from ambient atmosphere to the nostrils of subject 12 through body 14 during inhalation than for gas flowing from the nostrils of subject 12 to ambient atmosphere during exhalation (e.g., exhalation valves 28 may "close” during inhalation).
  • exhalation valves 28 are fixed resistors, and have the same resistance to gas flow regardless of the direction in which the gas is flowing. In either of these embodiments, the primary inlets to body 14 for gas from ambient atmosphere during inhalation will be gas flowing through inhalation valves 26 at inhalation ports 20. Thus, the cumulative resistance to the flow of inhaled gas from ambient atmosphere to the nostrils of subject 12 through body 14 is low enough by virtue of inhalation ports 20 that subject 12 is able to inhale through body 14 freely.
  • inhalation valves 26 block the flow of gas from body 14 to ambient atmosphere. This blockage may be accomplished by substantially sealing inhalation ports 20 and or by significantly restricting the flow of gas through inhalation ports 20.
  • inhalation valves 26 substantially seal inhalation ports 20 (e.g., provide a resistance to permit less than or equal to about 2.5 LPM (at 5 cm H 2 O pressure) of gas to flow out of inhalation ports 20).
  • inhalation valves 26 provide a resistance to gas flow out of body 12 during exhalation that is high enough in comparison with the resistance of exhalation valves 28 to the flow of gas from inside body 14 to ambient atmosphere that the resistance of exhalation valves 28 controls the cumulative resistance of body 14 to exhaled gas flowing to ambient atmosphere from the airway of subject 12.
  • the resistance of inhalation valves 26 to exhaled gas flowing from body 14 to atmosphere may be more than about 100 times smaller than the resistance of exhalation valves 28 to exhaled gas flowing from body 14 to atmosphere.
  • the resistance of inhalation valves 26 to exhaled gas flowing from body 14 to atmosphere may be more than about 50 times smaller than the resistance of exhalation valves 28 to exhaled gas flowing from body 14 to atmosphere. In one embodiment, the resistance of inhalation valves 26 to exhaled gas flowing from body 14 to atmosphere may be more than about five times smaller than the resistance of exhalation valves 28 to exhaled gas flowing from body 14 to atmosphere. In one embodiment, the resistance of inhalation valves 26 to exhaled gas flowing from body 14 to atmosphere may be smaller (e.g., more than about 2 times smaller) than the resistance of exhalation valves 28 to exhaled gas flowing from body 14 to atmosphere.
  • the resistance of exhalation valves 28 to the flow of gas from the nostrils of subject 12 to ambient atmosphere is configurable to adjust the cumulative resistance of respiration appliance 10 to gas flowing through body 14 from subject interface openings 18 to atmosphere during exhalation.
  • valves 28 may be associated with one or more controls through which subject 12 or an automated control mechanism can manipulate, and/or one or more of exhalation valves 28 may be selectably detachable from exhalation ports 22 for replacement by valves having the desired resistance.
  • selectable detachment of exhalation valves 28 may facilitate cleaning of appliance 10 and/or replacement of valves that have worn out.
  • the adjustment of resistance of exhalation valve 28 may include an adjustment to a diameter, a cross-sectional size, and/or an area of one or more openings in body 14 associated with exhalation valve 28.
  • exhalation ports 22 may be provided with the appropriate cumulative resistance to exhaled gas without the inclusion of separate exhalation valves 28.
  • the openings in body 14 at exhalation ports 22 may be formed having a shape and/or size that resists the flow of exhaled gas at a level that provides the flow paths within body 14 with the appropriate cumulative resistance to exhaled gas.
  • port 22 may not protrude from body 14 as is illustrated in FIG. 2 , but instead may be formed flush with, or more distributed over, the outer surface of body 14.
  • valves in body 14 that create the difference in cumulative resistance of respiration appliance 10 between inhalation gas flow and exhalation gas flow as including inhalation valves 26 and exhalation valves 28 as separate valves, or as being disposed in separate ports is not intended to be limiting.
  • the scope of this disclosure includes embodiments of respiration appliance 10 in which the functionality of inhalation valves 26 and exhalation valves 28 is achieved by a set of valves that each provide a different resistance between inhalation and exhalation.
  • respiration appliance 10 may include separate types of valves that are "stacked" within common ports (e.g., one variable resistance valve and on fixed resistor) to achieve the difference in cumulative resistance of respiration appliance 10 to inhalation and exhalation.
  • inhalation ports 20 to enable free inhalation through body 14, and exhalation ports 22 to provide a therapeutic resistance during exhalation may provide one or more enhancements over embodiments in which a single port or set of ports are provided with valves that both enable free inhalation and therapeutic resistance during exhalation through the same flow paths.
  • respiration appliance 10 can be formed using fixed resistors for exhalation valves 28, which are simpler, more reliable, and less costly (for parts and/or during assembly of the appliances) than the types of valves that must be implemented in appliances where each opening must provide free inhalation and a therapeutic exhalation resistance.
  • valves 26 and 28, and/or appliance 10 in general may be disposed outside of the nostrils of subject 12 (as is shown in the nasal pillow configuration of FIGS. 1 and 2 ).
  • some or all of the valves may have a larger cross-section than the openings of the nostrils, thereby enabling inhalation resistance of the valves 26 to be reduced.
  • exhalation valves 28 in separate parts from inhalation valves 26 is that the resistance of exhalation valves 28 can be made configurable (e.g., by replacement) without disturbing the functionality or integrity of inhalation valves 26.
  • respiration appliance 10 includes a mechanism configured to provide sensory cues to subject 12 to reduce the flow of exhalation gas from the airway of subject 12. Reducing the flow of exhalation gas from the airway of subject 12 may reduce a pressure differential between the one or more flow paths formed by the one or more bodies 14 and ambient atmosphere during exhalation.
  • the resistance of exhalation valves 28 causes pressure to build up within body 14 and the airway of subject 12 during exhalation as exhalation gas flows out of the airway of subject 12 into body 14 faster than gas flows out of body 14 to atmosphere. This pressure causes a pressure differential between the interior of body 14 and ambient atmosphere.
  • the pressure differential between the interior of body 14 and ambient atmosphere will tend to entrain the breathing of subject 12 to increase tidal volume and/or reduce respiratory rate (as described above).
  • subject 12 By training subject 12 to maintain the pressure different between body 14 and ambient atmosphere at a relatively low level during exhalation by voluntarily controlling the flow rate of exhalation through the airway, the subject may be trained to extend exhalation time even after respiration appliance 10 is no longer being used. This trained increase in exhalation time will be accompanied by an increase tidal volume and a reduction in respiratory rate (e.g., for the reasons described above) that extends beyond time periods during which subject 12 is using respiration appliance 10.
  • the breathing cues provided to subject 12 by the mechanism to reduce the pressure differential between the one or more flow paths formed by the one or more bodies and ambient atmosphere may have a positive impact on the breathing of subject 12 that outlasts the therapy sessions with respiration appliance 10.
  • the mechanism configured to provide sensory cues to subject 12 to reduce the pressure differential between the one or more flow paths formed by the one or more bodies and ambient atmosphere generates the cues if the pressure differential breaches a threshold pressure differential.
  • the sensory cues are auditory cues.
  • the auditory cues may be provided, for example, by one or more structures at or near exhalation valves 28 that whistle as the pressure differential between the interior of body 14 and ambient atmosphere approaches and/or breaches a threshold pressure differential. This whistle serves as an auditory cue to subject 12 to control exhalation through the airway to reduce the flow rate of exhalation into body 14.
  • the sensor cues are visual cues.
  • the visual cues may be provided, for example by a movable flap (e.g., about a hinge or flexible section) disposed at or near exhalation valves 28.
  • the flap is blown away from body 14 by the flow of gas from within body 14 to atmosphere through exhalation valves 28 if the pressure differential between the interior of body 14 and ambient atmosphere approaches and/or breaches a pressure differential threshold.
  • the movement of the flap serves as a visual cue to subject 12 to control exhalation through the airway to reduce the flow rate of exhalation into body 14.
  • FIG. 5 is a block diagram of respiration appliance 10 according to one embodiment of this disclosure.
  • respiration appliance 10 in addition to body 14, inhalation port 20, exhalation port 22, inhalation valve 26, and exhalation valve 28, respiration appliance 10 includes one or more sensors 30, a user interface 31, and a processor 32.
  • Sensors 30 are configured to generate one or more output signals that convey information related to one or more physiological parameters associated with breathing rate and/or tidal volume of respiration.
  • the physiological parameters may include one or more of a breathing parameter of the respiration of the subject, a cardiovascular parameter of the subject, a neurological parameter of the subject, and/or other physiological parameters impacted by and/or related to breathing rate and/or tidal volume.
  • a breathing parameter associated with breathing rate and/or tidal volume of respiration may include breathing rate, tidal volume, peak flow, breath period, inhalation period, exhalation period, and/or other breathing parameters.
  • Examples of a cardiovascular parameter associated with breathing rate and/or tidal volume of respiration may include pulse rate, pulse shape, blood pressure, blood oxygenation, and/or other cardiovascular parameters.
  • a neurological parameter of the subject may include an EEG and/or EMG reading, and/or other neurological parameters.
  • sensors 30 are carried on body 14.
  • sensors 30 may generate one or more output signals that are indicative of one or more parameters of gas at or near.the airway of the subject (e.g., within body 14).
  • the one or more parameters may include one or more of flow rate, pressure, and/or other parameters.
  • sensors 30 include one or more sensor that is configured to generate one or more output signals indicative of one or more cardiovascular parameters of the subject.
  • Such sensors may include, for example, a blood pressure cuff, a pressure transducer configured to detect pulse rate and/or shape, an oximeter configured to detect blood oxygenation, and/or other sensors.
  • User interface 31 is configured to provide an interface between appliance 10 and a user (e.g., the subject, a caregiver, a sleeping companion, etc.) through which the user may provide information to and receive information from appliance 10. This enables data, results, and/or instructions and any other communicable items, collectively referred to as "information," to be communicated between the user and processor 32.
  • interface devices suitable for inclusion in user interface 31 include a keypad, buttons, switches, a keyboard, knobs, levers, a display screen, a touch screen, speakers, a microphone, an indicator light, an audible alarm, and a printer.
  • user interface 31 may be integrated with a removable electronic storage interface.
  • information may be loaded into appliance 10 from removable storage (e.g., a smart card, a flash drive, a removable disk, etc.) that enables the user(s) to customize the implementation of appliance 10.
  • removable storage e.g., a smart card, a flash drive, a removable disk, etc.
  • Other exemplary input devices and techniques adapted for use with appliance 10 as user interface 31 include, but are not limited to, an RS-232 port, RF link, an IR link, modem (telephone, cable or other).
  • any technique for communicating information with appliance 10 is contemplated by the present invention as user interface 31.
  • Processor 32 is configured to provide information processing capabilities in respiration appliance 10.
  • processor 32 may include one or more of a digital processor, an analog processor, a digital circuit designed to process information, an analog circuit designed to process information, a state machine, and/or other mechanisms for electronically processing information.
  • processor 32 is shown in FIG. 5 as a single entity, this is for illustrative purposes only.
  • processor 32 may include a plurality of processing units. These processing units may be physically located within the same device, or processor 32 may represent processing functionality of a plurality of devices operating in coordination.
  • processor 32 may be configured to execute one or more computer program modules.
  • the one or more computer program modules may include one or more of a parameter module 34, a resistance module 36, a control module 38, a settings/modes module 40, a subject monitoring module 42, and/or other modules.
  • Processor 32 may be configured to execute modules 34, 36, 38, 40, and/or 42 by software; hardware; firmware; some combination of software, hardware, and/or firmware; and/or other mechanisms for configuring processing capabilities on processor 32.
  • modules 34, 36, 38, 40, and 42 are illustrated in FIG. 5 as being co-located within a single processing unit, in implementations in which processor 32 includes multiple processing units, one or more of modules 34, 36, 38, 40, and/or 42 may be located remotely from the other modules.
  • the description of the functionality provided by the different modules 34, 36, 38, 40, and/or 42 described below is for illustrative purposes, and is not intended to be limiting, as any of modules 34, 36, 38, 40, and/or 42 may provide more or less functionality than is described.
  • modules 34, 36, 38, 40, and/or 42 may be eliminated, and some or all of its functionality may be provided by other ones of modules 34, 36, 38, 40, and/or 42.
  • processor 32 may be configured to execute one or more additional modules that may perform some or all of the functionality attributed below to one of modules 34, 36, 38, 40, and/or 42.
  • the parameter module 34 is configured to determine information related to one or more physiological parameters related to tidal volume and/or breath rate of respiration of the subject.
  • the parameter module 34 may determine this information based on output signals generated by sensors 30.
  • the one or more physiological parameters may include one or more of a breathing parameter of the respiration of the subject, a cardiovascular parameter of the subject, and/or other physiological parameters impacted by and/or related to breathing rate and/or tidal volume.
  • a breathing parameter associated with breathing rate and/or tidal volume of respiration may include breathing rate, tidal volume, peak flow, breath period, inhalation period, exhalation period, and/or other breathing parameters.
  • Examples of a cardiovascular parameter associated with breathing rate and/or tidal volume of respiration may include pulse rate, pulse shape, blood pressure, blood oxygenation, and/or other cardiovascular parameters.
  • exhalation valve 28 may be configured to provide a controllable resistance to the flow of gas from the interior of body 14 to ambient atmosphere (e.g ., exhaled gas).
  • the resistance module 36 is configured to determine a cumulative resistance of respiration appliance 10 to exhalation by the subject. The cumulative resistance is determined by resistance module 36 to regulate the one or more physiological parameters related to tidal volume and/or breath rate of respiration of the subject. For example, resistance module 36 may determine the cumulative resistance to exhalation to ensure that the one or more physiological parameters remain at or near a target value.
  • the target value may be a therapeutically beneficial level for the one or more physiological parameters.
  • resistance module 36 determines the cumulative resistance of respiration appliance 10 to exhalation by the subject in a feedback manner. In this embodiment, resistance module 36 monitors determinations of information related to the one or more physiological parameter related to tidal volume and/or breath rate, and adjusts the cumulative resistance to exhalation to maintain the one or more physiological parameters at or near the target value(s).
  • resistance module 36 is configured to ramp the cumulative resistance to exhalation gradually over time such that the value of the one or more physiological parameters related to tidal volume and/or breathing rate are guided gradually to the target value(s). This may enhance the comfort of respiration appliance 10 to the subject upon initiating a session of treatment, which may tend to increase subject compliance.
  • the ramping of the cumulative resistance is performed by resistance module 36 according to a ramping algorithm.
  • the rate (and/or increments) at which the cumulative resistance is ramped may be determined based on response of the one or more physiological parameters to the cumulative resistance.
  • Control module 38 is configured to control the resistance of exhalation valve 28 to this flow of gas. More particularly, control module 36 controls the resistance of exhalation valve 28 to the flow of gas from the interior of body 14 to provide body 14 with the cumulative resistance to exhalation determined by resistance module 36. Controlling the resistance of exhalation valve 28 may include controlling a single valve, or a plurality of valves cooperating to provide the functionality attributed herein to exhalation valve 28.
  • the settings/modes module 40 is configured to control the mode that respiration appliance 10 is operating in, and/or the settings of respiration appliance 10.
  • the modes of operation of respiration appliance 10 may include a plurality of different modes.
  • the plurality of different modes may include different modes for breathing entrainment and for airway support. This would enable the subject to use respiration appliance 10 during the day (or even at night) for breathing entrainment , to impact the one or more physiological parameters related to tidal volume and/or respiratory rate, and use respiration appliance 10 at bedtime to provide airway support as treatment for sleep disordered breathing.
  • the settings/modes module 40 may automatically switch between these modes (e.g., based on a predetermined timing, an ambient radiation level, a motion sensor, and/or other sensors or detectors), and/or settings/modes module 40 may switch between these modes based on input for the subject (e.g., via user interface 31).
  • the settings of respiration appliance 10 include settings that control the manner in which the cumulative resistance of body 14 to exhalation is adjusted.
  • the settings may include a setting that dictates the target value of the one or more physiological parameters, a setting that dictates whether the cumulative resistance of body 14 to exhalation is ramped up upon commencement of use, a setting that dictates the rate at which the cumulative resistance of body 14 to exhalation is ramped, inhalation resistance, maximum or minimum pressure, pressure profile over the respiratory cycle, a defined control function that responds to sensory parameters (e.g ., systematically increasing resistance to reach a subject's goal of reduced blood pressure or sympathetic nervous activity, etc.), and/or other settings.
  • sensory parameters e.g ., systematically increasing resistance to reach a subject's goal of reduced blood pressure or sympathetic nervous activity, etc.
  • the subject monitoring module 42 is configured to monitor the subject deceiving treatment from respiration appliance 10. This includes monitoring the amount of therapy received by the subject from respiration appliance 10.
  • the amount of therapy received by the subject may be quantified in terms of the amount of time respiration appliance 10 is used, the impact on the one or more physiological parameters associated with tidal volume and/or respiratory rate, the amount of time for which the one or more physiological parameters satisfy the target value, and/or other mechanisms quantifying the amount of therapy received by the subject.
  • respiration appliance 10 may include a plurality of modes of operation that are selected by a user manually by a non-electronic interface provided on respiration appliance 10.
  • user interface 31 may include a dial or knob that mechanically adjusts the resistance of exhalation valve 28.
  • the dial or knob may indicate a plurality of positions that correspond to different settings (e.g., breath entrainment, pressure support, etc.).
  • one or more settings of respiration appliance 10 may be manually adjusted by the subject.
  • user interface 31 may include a knob, a dial, lever, a switch, and/or another interface that mechanically adjusts the resistance of exhalation valve 28 between resistance settings.
  • valve 28 could be accomplished by a mechanical mechanism for gradually restricting gas flow through valve 28 (e.g., by gradually restricting the diameter and/or cross-section of one or more openings formed at valve 28).
  • a memory polymer may be inserted in one or more openings formed at valve 28. The memory polymer may contract after being enlarged (e.g., by an inserted plug).
  • Valve 28 may include a memory metal/polymer/nano-structure that pulls or pushes a membrane (or. membranes) to close an opening associated with valve 28 after the membrane/memory structure is placed in an initial open position by a reset mechanism.
  • Valve 28 may include a spring-based clock-like mechanism that is released by breath pressure pressing against a membrane (or membranes) to slowly close an opening at valve 28.
  • Valve 28 may include a rocking-ratchet clock mechanism (fixed or pre-programmed time actuated) to slowly close a valve opening, Other mechanisms for slowly closing a valve opening associated with valve 28 to ramp resistance are also contemplated.
  • the mechanical mechanism included in valve 28 to slowly ramp resistance over time without control from an electrical processor may include an activation control.
  • the activation control may be activated by the subject or by another individual in the vicinity of subject during sleep (e.g., a spouse, a parent, a caregiver, etc.) as needed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Psychology (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Percussion Or Vibration Massage (AREA)

Claims (5)

  1. Beatmungsgerät (10), das konfiguriert ist, um die Atmung einer Person (12) zu erfassen, wobei das Beatmungsgerät (10) Folgendes umfasst:
    einen oder mehrere Körper (14), die konfiguriert sind, um eine oder mehrere äußere Öffnungen der Atemwege einer Person (12) zu umschließen, wobei der eine oder mehrere Körper (14) einen oder mehrere Strömungspfade zwischen der umschlossenen einen oder mehreren äußeren Öffnungen der Atemwege der Person und der Umgebungsatmosphäre bilden;
    ein oder mehrere Ventile (26, 28), die in dem einen oder mehreren Körpern (14) angeordnet sind, wobei das eine oder mehrere Ventile (26, 28) konfiguriert sind, um (i) einen kumulativen Einatmungswiderstand für die Gasströmung innerhalb des einen oder mehrerer Strömungspfade, die durch den einen oder mehrere Körper (14) gebildet werden, für Gas zu bilden, das aus der Umgebungsatmosphäre zu der einen oder mehreren äußeren Öffnungen der Atemwege der Person (12) strömt, die durch den einen oder mehrere Körper (14) umschlossen sind, und um (ii) einen kumulativen Ausatmungswiderstand für die Gasströmung innerhalb des einen oder mehrerer Strömungspfade, die durch den einen oder mehrere Körper (14) gebildet werden, für Gas zu bilden, das aus der einen oder mehreren äußeren Öffnungen der Atemwege der Person (12), die durch die einen oder mehreren Körper (14) umschlossen sind, zu der Umgebungsatmosphäre strömt,
    wobei der kumulative Einatmungswiderstand niedrig genug ist, damit die Person (12) die Umgebungsatmosphäre durch den einen oder mehrere Körper (14) frei einatmen kann, und
    wobei der kumulative Ausatmungswiderstand höher als der kumulative Einatmungswiderstand ist und so ausgewählt wird, dass die Ausatmung der Person (12) eingeschränkt wird, um die Ausatmungsdauer der Person (12) zu verlängern, wodurch die Atmung der Person (12) erfasst wird, währen die Person (12) bewusst ist, um das autonome Nervensystem der Person (12) so zu modulieren, um dass die Sympathikus-Aktivität verringert wird und/oder das Sympathikus/Parasympathikus-Gleichgewicht reduziert wird, um die Relaxation der Person (12) zu bewirken;
    dadurch gekennzeichnet, dass das Beatmungsgerät (10) weiterhin einen Trainingshinweis-Generator umfasst, der konfiguriert ist, um Atmungshinweise für die Person (12) zu erzeugen, die die Person (12) auffordern, eine Druckdifferenz zwischen dem einen oder mehreren Strömungspfaden, die durch den einen oder mehrere Körper (14) gebildet werden, und einer Umgebungsatmosphäre nur dann zu reduzieren, wenn die Druckdifferenz eine Schwellenwert-Druckdifferenz überschreitet.
  2. Beatmungsgerät nach Anspruch 1, wobei die Erfassung der Atmung der Person (12) in einer vorgegebenen Weise einen physiologischen Parameter moduliert, der zu der Atemfrequenz und/oder dem Tidalvolumen der Atmung gehörig ist.
  3. Beatmungsgerät nach Anspruch 2, wobei das eine oder mehrere Ventile (26, 28) konfiguriert sind, um eine Rückkopplungsregelung des kumulativen Ausatmungswiderstands basierend auf dem physiologischen Parameter zu ermöglichen.
  4. Beatmungsgerät nach Anspruch 3, das weiterhin Folgendes umfasst:
    einen oder mehrere Sensoren (30), die konfiguriert sind, um ein oder mehrere Ausgangssignale zu erzeugen, die Informationen bezüglich des physiologischen Parameters übermitteln; und
    einen Prozessor (32) in betriebsfähiger Kommunikation mit dem einen oder mehreren Sensoren (30), wobei der Prozessor (32) konfiguriert ist, um automatisch den Betrieb des einen oder mehrerer Ventile (26, 28) anzupassen, um den kumulativen Ausatmungswiderstand in einer Rückkopplungsweise basierend auf dem einen oder mehreren Signalen zu steuern, die durch den einen oder mehrere Sensoren (30) erzeugt werden.
  5. Beatmungsgerät nach Anspruch 2, wobei der physiologische Parameter einen oder mehrere von Atemfrequenz, Tidalvolumen, Pulsfrequenz oder Blutdruck umfasst.
EP10740730.6A 2009-07-09 2010-06-16 System und verfahren zur erfassung der atmung einer person Active EP2451517B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22411309P 2009-07-09 2009-07-09
PCT/IB2010/052713 WO2011004274A1 (en) 2009-07-09 2010-06-16 System and method for entraining the breathing of a subject

Publications (2)

Publication Number Publication Date
EP2451517A1 EP2451517A1 (de) 2012-05-16
EP2451517B1 true EP2451517B1 (de) 2016-12-07

Family

ID=42752005

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10740730.6A Active EP2451517B1 (de) 2009-07-09 2010-06-16 System und verfahren zur erfassung der atmung einer person

Country Status (8)

Country Link
US (1) US9789275B2 (de)
EP (1) EP2451517B1 (de)
JP (1) JP5802201B2 (de)
CN (1) CN102470230B (de)
AU (1) AU2010269886B2 (de)
BR (1) BR112012000151A8 (de)
RU (1) RU2546924C2 (de)
WO (1) WO2011004274A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2747610C2 (ru) * 2018-06-19 2021-05-11 Константин Леонидович Талашов Дыхательный внутриротовой тренажер, картридж для дыхательного внутриротового тренажера, способ тренировки при помощи заявленного дыхательного внутриротового тренажера

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7588033B2 (en) 2003-06-18 2009-09-15 Breathe Technologies, Inc. Methods, systems and devices for improving ventilation in a lung area
US8381729B2 (en) 2003-06-18 2013-02-26 Breathe Technologies, Inc. Methods and devices for minimally invasive respiratory support
CA2536090C (en) 2003-08-18 2014-07-22 Anthony D. Wondka Method and device for non-invasive ventilation with nasal interface
US7533670B1 (en) 2005-09-20 2009-05-19 Breathe Technologies, Inc. Systems, methods and apparatus for respiratory support of a patient
CA2652544A1 (en) 2006-05-18 2007-12-13 Breathe Technologies, Inc. Tracheostoma spacer, tracheotomy method, and device for inserting a tracheostoma spacer
US8978643B2 (en) * 2006-07-24 2015-03-17 Resmed Limited Modification of sympathetic activation and/or respiratory function
WO2008144589A1 (en) 2007-05-18 2008-11-27 Breathe Technologies, Inc. Methods and devices for sensing respiration and providing ventilation therapy
CN101888868B (zh) 2007-09-26 2014-01-22 呼吸科技公司 用于治疗睡眠呼吸暂停的方法和设备
US8567399B2 (en) 2007-09-26 2013-10-29 Breathe Technologies, Inc. Methods and devices for providing inspiratory and expiratory flow relief during ventilation therapy
EP2274036A4 (de) 2008-04-18 2014-08-13 Breathe Technologies Inc Verfahren und vorrichtungen zur messung von atmung und zur kontrolle der funktionen eines beatmungsgeräts
US8776793B2 (en) 2008-04-18 2014-07-15 Breathe Technologies, Inc. Methods and devices for sensing respiration and controlling ventilator functions
JP5715950B2 (ja) 2008-08-22 2015-05-13 ブリーズ・テクノロジーズ・インコーポレーテッド 開放気道インタフェースを有する機械換気を提供する方法及び装置
EP2344791B1 (de) 2008-10-01 2016-05-18 Breathe Technologies, Inc. Ventilator mit biofeedbacküberwachung und steuerung zur verbesserung der aktivität und gesundheit von patienten
US9216265B2 (en) * 2008-12-30 2015-12-22 Koninklijke Philips N.V. System and respiration appliance for supporting the airway of a subject
US9216266B2 (en) * 2008-12-30 2015-12-22 Koninklijke Philips N.V. System and respiration appliance for supporting the airway of a subject
US9132250B2 (en) 2009-09-03 2015-09-15 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
EP4218876A1 (de) 2009-04-02 2023-08-02 Breathe Technologies, Inc. Systeme zur nichtinvasiven offenen beatmung mit gasabgabedüsen in einem aussenrohr
US9962512B2 (en) 2009-04-02 2018-05-08 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with a free space nozzle feature
CA2774902C (en) 2009-09-03 2017-01-03 Breathe Technologies, Inc. Methods, systems and devices for non-invasive ventilation including a non-sealing ventilation interface with an entrainment port and/or pressure feature
EP2605836A4 (de) 2010-08-16 2016-06-01 Breathe Technologies Inc Verfahren, systeme und vorrichtungen unter verwendung von flüssigem sauerstoff zur atemunterstützung
US8939152B2 (en) 2010-09-30 2015-01-27 Breathe Technologies, Inc. Methods, systems and devices for humidifying a respiratory tract
US11406778B2 (en) 2011-06-15 2022-08-09 Koninklijke Philips N.V. Unlocking a respiratory mode
JP6395264B2 (ja) * 2011-06-15 2018-09-26 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 呼吸療法モードのアンロック
EP2968806A4 (de) * 2013-03-13 2016-12-07 Ge Sleeping Tech Ltd Verfahren und system zur beatmungsmodulation
US11890089B1 (en) 2015-07-28 2024-02-06 Thorasys Thoracic Medical Systems Inc. Flowmeter for airway resistance measurements
EP3368116B1 (de) * 2015-10-30 2021-08-18 Koninklijke Philips N.V. Atmungstrainings-, -überwachungs- und/oder -unterstützungsvorrichtung
WO2018071436A1 (en) * 2016-10-10 2018-04-19 Hupnos, Inc. Breathing mask and method
NL2019418B1 (en) * 2017-08-15 2019-02-25 Van Woerkum Holding B V Portable air treatment device and method for supplying filtered air to a person
US10792449B2 (en) 2017-10-03 2020-10-06 Breathe Technologies, Inc. Patient interface with integrated jet pump
US11759677B2 (en) 2018-02-16 2023-09-19 University Of Louisville Research Foundation, Inc. Respiratory training and airway pressure monitoring device
CN108671497A (zh) * 2018-07-13 2018-10-19 湖南气和医疗科技有限公司 气息训练检测装置及其检测方法
US20210370004A1 (en) * 2020-05-29 2021-12-02 Koninklijke Philips N.V. Oxygen pep cannula

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511228A (en) 1964-06-04 1970-05-12 Claes Erik Gunnar Lundgren Bronchial dilator for patients suffering from emphysema and asthma or the like
US3710780A (en) 1971-08-05 1973-01-16 R Milch Respiratory device with variable expiratory pressure resistance
US3869771A (en) * 1973-10-17 1975-03-11 Charles W Bollinger Device for regulating positive end expiratory pressure
US5050593A (en) 1990-06-01 1991-09-24 Massachusetts Institute Of Technology Respirator triggering mechanism
US5598839A (en) * 1994-04-20 1997-02-04 Diemolding Corporation Positive expiratory pressure device
RU2164805C1 (ru) * 1999-10-08 2001-04-10 Открытое акционерное общество Акционерная компания "Туламашзавод" Устройство для дыхательных упражнений
US20050165322A1 (en) * 2004-01-23 2005-07-28 Bryant Terry K. Method of improving medical apparatus in order to reduce or replace ancillary medical assistance by employing audible verbal human sounding voices which provide therapeutic instructions and encourage usage and give measurements as needed emanating from the apparatus's by using electronic technology
BRPI0518641B8 (pt) * 2004-12-08 2021-06-22 Ventus Medical Inc dispositivo respiratório nasal
WO2007033347A2 (en) * 2005-09-12 2007-03-22 Mergenet Medical, Inc. Nasal cannula
EP2026723B1 (de) * 2006-05-23 2018-11-21 Theravent, Inc. Nasenatemgeräte
CN101489630B (zh) * 2006-06-07 2013-10-23 温吐斯医学公司 分层鼻装置
US7556038B2 (en) 2006-08-11 2009-07-07 Ric Investments, Llc Systems and methods for controlling breathing rate
JP2009082175A (ja) * 2007-09-27 2009-04-23 Omron Healthcare Co Ltd 呼吸訓練器およびコンピュータプログラム
US20090308398A1 (en) * 2008-06-16 2009-12-17 Arthur Ferdinand Adjustable resistance nasal devices
US9216265B2 (en) * 2008-12-30 2015-12-22 Koninklijke Philips N.V. System and respiration appliance for supporting the airway of a subject

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2747610C2 (ru) * 2018-06-19 2021-05-11 Константин Леонидович Талашов Дыхательный внутриротовой тренажер, картридж для дыхательного внутриротового тренажера, способ тренировки при помощи заявленного дыхательного внутриротового тренажера

Also Published As

Publication number Publication date
EP2451517A1 (de) 2012-05-16
JP5802201B2 (ja) 2015-10-28
RU2546924C2 (ru) 2015-04-10
WO2011004274A1 (en) 2011-01-13
JP2012532645A (ja) 2012-12-20
AU2010269886B2 (en) 2015-07-30
CN102470230A (zh) 2012-05-23
BR112012000151A8 (pt) 2017-10-10
US20120085347A1 (en) 2012-04-12
CN102470230B (zh) 2014-12-17
BR112012000151A2 (pt) 2017-07-25
RU2012104540A (ru) 2013-08-20
AU2010269886A1 (en) 2012-03-01
US9789275B2 (en) 2017-10-17

Similar Documents

Publication Publication Date Title
EP2451517B1 (de) System und verfahren zur erfassung der atmung einer person
JP6223322B2 (ja) 被験者の気道をサポートするための呼吸機器
JP5723785B2 (ja) 被験者の気道をサポートするためのシステム、方法及び呼吸機器
EP2432537B1 (de) System zur aufforderung einer person zur veränderung von ein oder mehr atemparametern
EP2384174B1 (de) System und atemvorrichtung zur unterstützung der atemwege einer person
EP2384212B1 (de) System und atemvorrichtung zur unterstützung der atemwege einer person
EP2691136B1 (de) Übergangsverfahren neben oder in verbindung mit einer sekundären atemwegsdrucktherapie

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120209

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: KONINKLIJKE PHILIPS N.V.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160616

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 16/06 20060101AFI20160603BHEP

Ipc: A63B 24/00 20060101ALN20160603BHEP

Ipc: A63B 21/008 20060101ALN20160603BHEP

Ipc: A61M 21/00 20060101ALI20160603BHEP

Ipc: A61M 16/00 20060101ALN20160603BHEP

Ipc: A63B 23/18 20060101ALI20160603BHEP

Ipc: A61M 16/08 20060101ALN20160603BHEP

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 851196

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161215

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602010038627

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170307

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170308

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 851196

Country of ref document: AT

Kind code of ref document: T

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170407

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170307

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170407

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602010038627

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20170908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20170616

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170630

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170616

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170616

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170616

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170630

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20100616

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161207

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230622

Year of fee payment: 14

Ref country code: DE

Payment date: 20230627

Year of fee payment: 14